(Q53167302)
Statements
Impact of adalimumab treatment on health-related quality of life and other patient-reported outcomes: results from a 16-week randomized controlled trial in patients with moderate to severe plaque psoriasis. (English)
1 reference
D Revicki
1 reference
M K Willian
1 reference
J-H Saurat
1 reference
K A Papp
1 reference
J-P Ortonne
1 reference
C Sexton
1 reference
A Camez
1 reference
28 November 2007
1 reference
158
1 reference
549-557
1 reference
3
1 reference
1 reference
Identifiers
1 reference